<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Paris_Saclay_Notebook_August_26 skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Paris Saclay/Notebook/August/26</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="container-fluid nav-container"><NAV class="navbar navbar-default navbar-inverse affix-top" data-spy="affix" data-offset-top="260"><DIV class="container-fluid"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1" aria-expanded="false"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON></DIV><DIV class="collapse navbar-collapse" id="bs-example-navbar-collapse-1"><UL class="nav navbar-nav center-block"><LI><A href="https://2016.igem.org/Team:Paris_Saclay">Home</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Team</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Team">Team</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Media">Media</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Collaborations">Collaborations</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Sponsors">Sponsors</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Acknowledgements">Acknowledgements</A></LI></UL><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Project </A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Background">Background</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Design">Design</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/CRISPR-Cas9">CRISPR/Cas9</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Strategy">Strategy</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Experiments">Experiments</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Notebook">Notebook</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Description">Results</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Perspective">Perspective</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Interlab_Study">Interlab Study</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Parts</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Parts">Parts</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Basic_Part">Basic Parts</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Composite_Part">Composite Parts</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Human Pratices </A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Human_Practices">Overview</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/HP/Silver">Societal Issues of CRISPR/Cas9</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/HP/Gold">Responsible Research and Innovation</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Human_Practices/GMO_Regulation">GMO regulation</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Integrated_Practices">Integrated Practices</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Engagement">Engagement</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Model">Model</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Attributions">Attributions</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Safety">Safety</A></LI></DIV></DIV></NAV></DIV><DIV class="container content"><DIV id="main"><DIV id="toc" class="toc"><DIV id="toctitle"><H2>Contents</H2></DIV><UL><LI class="toclevel-1 tocsection-1"><A href="#Friday_26th_August"><SPAN class="tocnumber">1</SPAN><SPAN class="toctext">Friday 26<SUP>th</SUP> August</SPAN></A></LI><LI class="toclevel-2 tocsection-2"><A href="#Visualization"><SPAN class="tocnumber">1.1</SPAN><SPAN class="toctext">Visualization</SPAN></A></LI><LI class="toclevel-3 tocsection-3"><A href="#Purification_of_pPS16-003_and_pPS16_004_ligation_products"><SPAN class="tocnumber">1.1.1</SPAN><SPAN class="toctext">Purification of pPS16-003 and pPS16_004 ligation products</SPAN></A></LI><LI class="toclevel-3 tocsection-4"><A href="#Q5_high_fidelity_PCR_of_pPS16_003_-_pPS16_004_ligation_product"><SPAN class="tocnumber">1.1.2</SPAN><SPAN class="toctext">Q5 high fidelity PCR of pPS16_003 - pPS16_004 ligation product</SPAN></A></LI><LI class="toclevel-3 tocsection-5"><A href="#Purification_of_fragments_1.2816-001_.2B_pPS16_002.29_and_2_.2816-003_.2B_pPS16_004.29"><SPAN class="tocnumber">1.1.3</SPAN><SPAN class="toctext">Purification of fragments 1(16-001 + pPS16_002) and 2 (16-003 + pPS16_004)</SPAN></A></LI><LI class="toclevel-3 tocsection-6"><A href="#Gibson_Assembly_of_segments_1_and_2"><SPAN class="tocnumber">1.1.4</SPAN><SPAN class="toctext">Gibson Assembly of segments 1 and 2</SPAN></A></LI><LI class="toclevel-3 tocsection-7"><A href="#Transformation_in_DH5.CE.B1_with_the_1-2_Gibson_assembly_product"><SPAN class="tocnumber">1.1.5</SPAN><SPAN class="toctext">Transformation in DH5α with the 1-2 Gibson assembly product</SPAN></A></LI></UL></DIV><H1><SPAN class="mw-headline" id="Friday_26th_August">Friday 26<SUP>th</SUP> August</SPAN></H1><H3><SPAN class="mw-headline" id="Visualization">Visualization</SPAN></H3><H4><SPAN class="mw-headline" id="Purification_of_pPS16-003_and_pPS16_004_ligation_products">Purification of pPS16-003 and pPS16_004 ligation products</SPAN></H4><P><I>By Mathilde</I></P><P>Ligation products pPS16-003 and pPS16_004 frome the <A href="/Team:Paris_Saclay/Notebook/August/25#Visualization" title="Team:Paris Saclay/Notebook/August/25">day before</A> were purificated according to the usual <A href="/Team:Paris_Saclay/Experiments#Purification_:_PCR_clean-up_with_NucleoSpin_Gel_and_PCR_Clean-up" title="Team:Paris Saclay/Experiments">protocol</A></P><H4><SPAN class="mw-headline" id="Q5_high_fidelity_PCR_of_pPS16_003_-_pPS16_004_ligation_product">Q5 high fidelity PCR of pPS16_003 - pPS16_004 ligation product</SPAN></H4><P><I> By Mathilde </I></P><P>The Q5 PCR was conducted following the exact same protocol than the <A href="/Team:Paris_Saclay/Notebook/August/25#Visualization" title="Team:Paris Saclay/Notebook/August/25">25/08/2016</A> on the ligation product from the day before.
</P><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:402px;"><DIV class="thumbcaption">Migration Results</DIV></DIV></DIV></DIV><P>The two bands are at the expected size (1860 pb), so the fragment 2 (16-003 and pPS16_004 ligation product) is purified.
</P><H4><SPAN class="mw-headline" id="Purification_of_fragments_1.2816-001_.2B_pPS16_002.29_and_2_.2816-003_.2B_pPS16_004.29">Purification of fragments 1(16-001 + pPS16_002) and 2 (16-003 + pPS16_004)</SPAN></H4><P><I> By Mathilde</I></P><P>The purification was made following the usual <A href="/Team:Paris_Saclay/Experiments#Purification_:_PCR_clean-up_with_NucleoSpin_Gel_and_PCR_Clean-up" title="Team:Paris Saclay/Experiments">protocol</A>.
Each of those purification products were quantified on nanodrop. 
</P><TABLE class="wikitable"><TBODY><TR><TH>Segment
</TH><TH>DNA quantity (ng/µL)
</TH><TH>260/230
</TH><TH>260/280
</TH></TR><TR><TD>1
</TD><TD>84,20
</TD><TD>1,25
</TD><TD>1,84
</TD></TR><TR><TD>2
</TD><TD>169,88
</TD><TD>1,29
</TD><TD>1,83
</TD></TR></TBODY></TABLE><P>Enough DNA quantity was obtained to perform a Gibson assembly on segments 1 and 2.
</P><H4><SPAN class="mw-headline" id="Gibson_Assembly_of_segments_1_and_2">Gibson Assembly of segments 1 and 2</SPAN></H4><P><I>By mathilde</I></P><P>Two preparations were made :
</P><UL><LI> the 1-2 Gibson assembly product tube : 1,12µL of purified segment 1 and 0,56µL of purified segment 2 +  0,85µL of digested pSB1C3 + 7,47 µL of sterile water + 10µL of NEB Builder Hifi DNA Assembler Master Mix </LI><LI> the control tube : 0,85µL of digested pSB1C3 + 17,47 µL of sterile water</LI></UL><P>Gibson products were incubated 1h at 52°c.
</P><H4><SPAN class="mw-headline" id="Transformation_in_DH5.CE.B1_with_the_1-2_Gibson_assembly_product">Transformation in DH5α with the 1-2 Gibson assembly product</SPAN></H4><P><I>By Mathilde</I></P><P>The transformation was performed following the usual <A href="/Team:Paris_Saclay/Experiments#Heat_shock_competent_cells" title="Team:Paris Saclay/Experiments">protocol</A> with 2µL of plasmid.
</P><UL><LI> 50, 150 and 350µL of the transformed DH5α with the 1-2 Gibson assembly product were plated on 3 plates of LB + chloramphenicol (30µg/mL)</LI><LI> 350 µL of each Gibson assembly control and transformation control were plated on 2 plates of B + chloramphenicol (30µg/mL)</LI></UL><P>Petri cultures were incubated at 37°c overnight.
</P></DIV></DIV><DIV class=" footer"><DIV class="container"><DIV class="adress"><ADRESS>Université Paris Sud
91405 Orsay, France</ADRESS></DIV><SMALL class="envers copyright">Copyright © 2016 iGEM Paris Saclay. <STRIKE>All rights reserved</STRIKE> All inspirations encouraged.*This wiki was conceived during long nights of work and a great coffee experience in the beautiful Orsay, France.</SMALL></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>